henhaobio
Sign in

bioRxivMicrobiologyPreprint

PluMu - a Mu-like bacteriophage infecting Actinobacillus pleuropneumoniae

L. J. Bartsch, R. Fernandez Crespo, Y. Wang, M. A. Skinner, A. N. Rycroft, W. Cooley, D. J. Everest, Y. Li, J. T. Bosse, P. R. Langford

PDFDOI

Abstract

Actinobacillus pleuropneumoniae is the causative agent of pleuropneumonia, an economically important lung disease of pigs. In draft genomes of two Cypriot clinical A. pleuropneumoniae isolates (MIDG3457 and MIDG3459), we previously identified single genomic regions with homology to Mu-like bacteriophage and presented preliminary evidence of active phage. Here, updated Phastest genomic analysis identified two loci in both MIDG3457 and MIDG3459 that were predicted to encode proteins with high homology to, and whose organization was characteristic of, Mu-like phages. Phylogenetically, the closest matches were with Mannheimia Vb and Glaesserella SuMu phages. Phastest scored the loci as "complete", indicating they produced active phage. PCR amplification of the Mu-like phage c and tail genes from DNase-treated polyethylene glycol 8000 (PEG)-precipitated supernatants of MIDG3457 and MIDG3459 (grown in either Brain Heart Infusion-NAD or Graces Insect Medium-NAD broth) indicated the presence of intact virions. The phages from MIDG3457 and MIDG3459 were named PluMu 3457-1, 3457-2, and PluMu 3459-1 and PluMu 3459-2, respectively. Transmission electron microscopy (TEM) of PEG-precipitated supernatants of broth-grown MIDG3459 identified virions with icosahedral heads and tails, consistent with other Mu-like phages. We conclude that MIDG3459 produces an active Mu- like phage.

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISSantoro '22Urtecho '20Lloyd-Evans '26Câlin '26Li '21Billaud '25
65% semantic matchMicrobiology
F. Santoro, G. Pastore, V. Fox+3 more·bioRxiv·Oct 13, 2022